Using accelerometers to measure physical activity in cancer patients
Official title: APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials. A Feasibility Study Evaluating the Use of Accelerometers to Capture Physical Activity Levels in Cancer Patients on Early Phase Clinical Trials
Run by University of Manchester · NCT06868355 · Data updated 2026-11-12
This study is testing whether wearing a device that tracks movement can help cancer patients understand their activity levels and fatigue during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Manchester Academic / other |
| Locations | 8 sites (Milan and 7 other locations) |
| Status | Recruiting |
| Started | September 28, 2023 |
| Main results expected | September 30, 2025 |
| Study ends | September 30, 2025 |
| Registry record updated | August 14, 2025 |
| Trial ID | NCT06868355 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include cancer patients aged 16 and older who are enrolled in early phase clinical trials and can comply with study procedures.
✕Probably not a fit
Patients who are not eligible for early phase clinical trials or those unable to comply with study requirements may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the feasibility of using wearable accelerometers to collect data on physical activity and sleep patterns in cancer patients enrolled in early phase clinical trials. Over a period of 5-6 weeks, participants will wear the device to provide insights into their activity levels and fatigue, which are critical for managing their treatment and interventions. The study seeks to improve the understanding of how physical activity impacts cancer patient outcomes, particularly in those experiencing treatment-related fatigue.
Why it matters
Potential benefit: If successful, this study could lead to better management of physical activity and fatigue in cancer patients, enhancing their treatment outcomes.
How similar studies have gone: While the use of accelerometers in other populations has shown promise, this specific approach in cancer patients on early phase clinical trials is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntary informed consent. * Aged at least 16 years. * Consented to an early phase clinical trial. * Willingness to wear a device for the duration of the study. * Willingness to comply with scheduled study procedures. * ECOG PS 0 or 1. Exclusion Criteria: * Judgement by the investigator that the individual should not participate if they are unlikely to comply with study procedures and requirements. * Patient deemed ineligible for enrolment onto an early phase clinical trial.
Where it's running
-
National Cancer Institute of Milan (INT)
Milan, Italy Recruiting -
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Spain Recruiting -
Clínica Universidad de Navarra
Pamplona, Spain Recruiting -
Instituto de Investigación Sanitaria (INCLIVA)
Valencia, Spain Recruiting -
START Madrid CIOCC
Madrid, Spain Not yet recruiting -
START Madrid Fundación Jiménez Díaz (FJD) Quiron Salud Hospital
Madrid, Spain Not yet recruiting
Show 2 more locations
-
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom Completed -
The Christie NHS Foundation Trust
Manchester, United Kingdom Completed
Study contacts
- Study coordinator: Gayle Patterson
- Email: gayle.patterson@manchester.ac.uk
- Phone: 07919719013
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inflammation, infection and treatments during severe cystic fibrosis flare-ups
Researchers will follow people with cystic fibrosis who are at risk of severe lung flare-ups to see if symptoms, lung tests, and biological samples explain different responses to intravenous antibiotics.
-
UK multicentre hypertrophic cardiomyopathy registry
This project collects health information from adults with hypertrophic cardiomyopathy across UK NHS hospitals to see which treatments and tests work best for different patients.
-
Culturally adapted CBT for psychosis in Black people in the UK
A small series tests whether culturally tailored cognitive-behavioral therapy for psychosis is doable, acceptable, and safe for Black Sub-Saharan African and Caribbean individuals in the UK.
-
Making AI triage more accurate for patients contacting their GP
This project will test whether updated AI in the Patchs online consultation system can make triage decisions more accurate and fair for patients contacting GP practices in England.
-
Camzyos and heart blood flow in HOCM: a PET imaging study
This trial tests if Camzyos (mavacamten) can improve blood flow to the heart muscle in people with HOCM who have chest pain or shortness of breath.
-
New sensor for monitoring fetal health during late pregnancy
This study is testing a new non-adhesive sensor to see if it can accurately monitor the heart rates of pregnant women and their babies during late pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.